Labshake search
Citations for Bio X Cell :
401 - 450 of 1254 citations for Mouse Anti Tick borne Encephalitis Virus NS1 M838 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... anti-CD8 (BioXcell, 2.43), anti-CD45 (BioLegend ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-PD1 (BioXCell # BE0146), and anti-CTLA-4 (BioXCell # BE0164 ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-CD3 (BioXcell, 17A2), and anti-CK8 (BioLegend ...
-
bioRxiv - Immunology 2023Quote: ... anti-CXCR3 (BE0249, BioXcell) and anti-IFN-γ (BE0055 ...
-
bioRxiv - Microbiology 2024Quote: ... Anti-CD8 antibody (BioXCell) or rat IgG2b isotype control (BioXCell ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-CD8 (BioXCell, BE0061) or isotype control (BioXCell ...
-
bioRxiv - Cancer Biology 2023Quote: ... and Vehicle+anti-PD-1 and UNC0642+anti-PD-1 mice were treated with 200 μg anti-PD-1 (BioXCell, BE0273) via intraperitoneal (i.p. ...
-
bioRxiv - Cancer Biology 2020Quote: ... Anti-PD1 (clone RMP1-14) and anti-CTLA4 (clone 9D9) were from BioXcell. Anti-Batf3 antibody was purchased from Abcam (#ab211304).
-
bioRxiv - Immunology 2019Quote: ... anti-α4 integrin PS/2 and anti-αE integrin M290 were from BioXCell, anti-αV integrin RMV-7 was from BioLegend ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-PD1 treatment: Purified anti-mPD-1 antibody (BioXcell #BE0033-2; clone J43) was used for in vivo PD-1 blockade at a dosage of 200 μg/mouse through i.p ...
-
bioRxiv - Bioengineering 2021Quote: ... Mouse IgG1 isotype control antibody (clone MOPC-21) was purchased from Bio X Cell. Tag-free and histidine tagged human IL-12 were both purchased from Sino Biologicals.
-
bioRxiv - Cancer Biology 2022Quote: ... or 200μg of InVivoMAb mouse IgG2a isotype control antibody (clone C1.18.4, Bio X Cell). For in vivo blocking of NKG2A ...
-
bioRxiv - Cancer Biology 2023Quote: ... or InVivoMAb mouse IgG1 isotype control (clone MOPC-21; #BE0083, Bio X Cell, USA) or conditioned-media from 24 h-rested ...
-
bioRxiv - Cancer Biology 2023Quote: ... each mouse was injected with 250 ug rat IgG2a (BioXcell, catalog #BE0089, clone 2A3) and 200 ug IgG2b (BioXcell ...
-
bioRxiv - Immunology 2021Quote: ... 2 µg/mL anti-IL-4 and anti-IFNγ antibody (BioXcell, Clone: XMG 1.2). 10 µM SB525334 was used to replace TGF-β to inhibit TGF-β signaling if required ...
-
bioRxiv - Immunology 2019Quote: Mice were intraperitoneally injected with 400ug anti-CD4 GK1.5 or anti-CD8 2.43 (BioXcell) in PBS at D-1 ...
-
bioRxiv - Immunology 2019Quote: ... anti-human CD3 (OKT3, Bio X cell, anti-human CD28 (9.3 Bio X Cell), anti-human CD45 (REA747 ...
-
bioRxiv - Immunology 2019Quote: ... anti-human CD3 (OKT3, Bio X cell, anti-human CD28 (9.3 Bio X Cell), anti-human CD45 (REA747 ...
-
bioRxiv - Immunology 2020Quote: ... each of anti-LFA-1 and anti-VLA-4 blocking antibodies (Bio X Cell) or control IgG ...
-
PD-1 checkpoint blockade disrupts CD4 T cell regulated adaptive B cell tolerance to foreign antigensbioRxiv - Immunology 2021Quote: ... anti-trinitrophenol (clone 2A3, BioXcell). For CD4 depletion ...
-
bioRxiv - Immunology 2022Quote: ... anti-PSGL-1 (4RA10, BioXcell), or both for 15 minutes at 4°C ...
-
bioRxiv - Immunology 2022Quote: ... and anti-CD28 (37.51, BioXcell)(5 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Microbiology 2021Quote: ... anti-CD8 (clone YTS169.4, BioXCell); or both ...
-
bioRxiv - Microbiology 2021Quote: ... anti-IFNγ (clone XMG1.2, BioXCell) or Rat IgG1 isotype control ...
-
bioRxiv - Cancer Biology 2020Quote: ... Anti-PD-1 (BioXcell, BE0146) or isotype control (BioXcell ...
-
bioRxiv - Microbiology 2022Quote: ... anti-Ly6G (BioXCell; clone 1A8) or an isotype control (BioXCell ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-CD8 (clone 2.43, BioxCell), anti-CD11b (clone M1/70 ...
-
bioRxiv - Cancer Biology 2020Quote: Anti-CD8 (#BE0004-1, BioXCell) and anti-CD4 (#BE0003-1 ...
-
bioRxiv - Immunology 2019Quote: Anti-ICOSL (HK5.3, Bioxcell, #BE0028) treatment was performed by i.p ...
-
bioRxiv - Immunology 2021Quote: ... Anti-PD1 (RMP1-14, BioXCell) was diluted in PBS to a concentration of 1 mg/ml for intraperitoneal administration of 100 ug ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-PD1 (29F.1A12, Bioxcell), anti-PD-L1 (10F.9G2 ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-PD1 (29F.1A12, Bioxcell) was used ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-CD4 (GK1.5, Bioxcell) were used ...
-
bioRxiv - Immunology 2020Quote: Anti-VEGFR2 (clone DC101, BioXCell) or isotype control antibody (clone HRPN ...
-
bioRxiv - Immunology 2020Quote: ... agonist-anti CD40 antibody (BioXCell), and vaccine-grade poly(I:C) ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CD8 (BioXCell, BE0061) or isotype control (BioXCell ...
-
bioRxiv - Cancer Biology 2020Quote: ... Anti-CD4 (BioXCell, BE0003-1) and anti-CD8 (BioXCell ...
-
bioRxiv - Immunology 2022Quote: ... 100ug anti-TGFb antibody (Bioxcell) per mouse per dose was administered by IP injection.
-
bioRxiv - Immunology 2022Quote: ... and anti-CD28 (37.51; BioXcell). In this 2-steps RV transduction system ...
-
bioRxiv - Immunology 2022Quote: ... and anti-IFNAR1 (BE00241; BioXCell), the pan caspase inhibitor Z- VAD-FMK (HY-16658B ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-CD40 clone G28.5 (BioXCell), anti-hPD-L1-hIgG1 (Invivogen) ...
-
bioRxiv - Cell Biology 2023Quote: ... 200ug/100uL anti-Timd4 (BioXCell), or equivalent unit IgG control (R&D ...
-
bioRxiv - Cancer Biology 2022Quote: ... 0.5 mg anti-IL6 (BioXCell) was injected intraperitoneally starting 6 hours before irradiation ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-trinitrophenol (BioXCell, Cat. #BE0079). InVivoPure pH 6.5 dilution buffer (BioXCell ...
-
bioRxiv - Immunology 2022Quote: ... or anti-IL1β (BioXCell, B122), respectively ...
-
bioRxiv - Immunology 2023Quote: ... anti-IL-1β (B122; BioXCell), anti-IFNγ (XMG1.2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-human CD3 antibody (BioXCell) was added at a final concentration of 1 μg/106 cells to avoid potential graft-versus-host disease ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-human CD3 antibody (BioXCell) was added at a final concentration of 1 μg/106 cells to avoid potential graft-versus-host disease ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-PD-1 (BioXCell, BE0146) or isotype control (BioXCell ...